A detailed history of Two Sigma Investments, LP transactions in Gh Research PLC stock. As of the latest transaction made, Two Sigma Investments, LP holds 16,761 shares of GHRS stock, worth $183,868. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,761
Holding current value
$183,868
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$6.3 - $10.95 $105,594 - $183,532
16,761 New
16,761 $117,000
Q4 2023

Feb 14, 2024

BUY
$5.26 - $11.04 $76,170 - $159,870
14,481 New
14,481 $83,000

Others Institutions Holding GHRS

About GH Research PLC


  • Ticker GHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,020,800
  • Market Cap $571M
  • Description
  • GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...
More about GHRS
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.